How many insider trades does FilingIQ track for OTLK?

FilingIQ tracks 115 Form 4 insider transactions for OTLK (Outlook Therapeutics, Inc.), covering filings from Dec 3, 2018 onwards. 4 of those were filed in the last 90 days.

Are OTLK insiders net buyers or net sellers?

Across the full Form 4 history for OTLK, 69 transactions (60%) were open-market purchases and 11 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OTLK insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OTLK in?

Outlook Therapeutics, Inc. (OTLK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.41M.

OTLK insider trading

NasdaqCM Healthcare

Outlook Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

115

Last 90 days

Buys / sells

60% / 10%

Market cap

$22.41M

About Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Company website: outlooktherapeutics.com

OTLK insider activity at a glance

FilingIQ has scored 115 insider transactions for OTLK since Dec 3, 2018. The most recent filing in our index is dated May 27, 2026.

Across the full history, 69 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OTLK insider trades is 60.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OTLK trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,265

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 195

Guardant Health, Inc.

ADPT 184

Adaptive Biotechnologies Corp

BMY 182

BRISTOL MYERS SQUIBB CO

VTRS 165

Viatris Inc

ALNY 153

ALNYLAM PHARMACEUTICALS, INC.

Frequently asked

How many insider trades does FilingIQ track for OTLK?: FilingIQ tracks 115 Form 4 insider transactions for OTLK (Outlook Therapeutics, Inc.), covering filings from Dec 3, 2018 onwards. 4 of those were filed in the last 90 days.
Are OTLK insiders net buyers or net sellers?: Across the full Form 4 history for OTLK, 69 transactions (60%) were open-market purchases and 11 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OTLK insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OTLK in?: Outlook Therapeutics, Inc. (OTLK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.41M.

Methodology & sources

Every OTLK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.